CLEVELAND — With myriad treatment options now available for psoriasis vulgaris, recent research is focusing on reaching higher goals, Anthony P. Fernandez, MD, PhD, said at the Medical Dermatology Therapy Update III meeting.
“We are more spoiled in psoriasis than in any disease space in dermatology in terms of the weapons we have available to us,” Fernandez, clinical assistant professor of medicine at Cleveland Clinic’s Lerner College of Medicine, the meeting’s activity director and a member of the Healio Dermatology Peer Perspective Board, said.
With 14 systemic